Lupin, Dr Reddy's Labs recall products in US over manufacturing issues: USFDA
New Delhi: Pharma majors Lupin, Dr Reddy's Laboratories are recalling products in the US over manufacturing issues, according to a latest enforcement report by the US Food and Drug Administration (USFDA).
The US-based arm of the Mumbai-based drug maker Lupin is recalling the 4,554 bottles of Cefixime for Oral Suspension, used to treat bacterial infections in the market, on account of it being "Subpotent".
According to PTI report, Baltimore-based Lupin Pharmaceuticals Inc. initiated the Class II recall on August 21.
As per the USFDA, a Class II recall is initiated in a situation in which the use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.
Dr Reddy's Laboratories Inc, a subsidiary of Hyderabad-based drug firm, is recalling Ibuprofen tablets in multiple strengths, the US health regulator said in its latest enforcement report.
